HLA-B57 micropolymorphism defines the sequence and conformational breadth of the immunopeptidome.
Illing, P.T., Pymm, P., Croft, N.P., Hilton, H.G., Jojic, V., Han, A.S., Mendoza, J.L., Mifsud, N.A., Dudek, N.L., McCluskey, J., Parham, P., Rossjohn, J., Vivian, J.P., Purcell, A.W.(2018) Nat Commun 9: 4693-4693
- PubMed: 30410026 
- DOI: 10.1038/s41467-018-07109-w
- Primary Citation of Related Structures:  
5VUD, 5VUE, 5VUF, 5VVP, 5VWD, 5VWF, 5VWH, 5VWJ - PubMed Abstract: 
Immunophenotypic differences between closely related human leukocyte antigen (HLA) alleles have been associated with divergent clinical outcomes in infection, autoimmunity, transplantation and drug hypersensitivity. Here we explore the impact of micropolymorphism on peptide antigen presentation by three closely related HLA molecules, HLA-B*57:01, HLA-B*57:03 and HLA-B*58:01, that are differentially associated with the HIV elite controller phenotype and adverse drug reactions ...